HomeADMA • NASDAQ
ADMA Biologics Inc
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 117.55M | 59.06% |
Operating expense | 25.01M | 54.83% |
Net income | 111.90M | 734.15% |
Net profit margin | 95.19 | 498.62% |
Earnings per share | 0.14 | 257.89% |
EBITDA | 40.17M | 109.94% |
Effective tax rate | -222.35% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.15M | 100.86% |
Total assets | 488.68M | 48.45% |
Total liabilities | 139.66M | -28.00% |
Total equity | 349.02M | — |
Shares outstanding | 237.62M | — |
Price to book | 13.12 | — |
Return on assets | 21.79% | — |
Return on capital | 24.74% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 111.90M | 734.15% |
Cash from operations | 50.22M | 185.37% |
Cash from investing | -2.75M | -95.45% |
Cash from financing | -31.03M | 20.44% |
Net change in cash | 16.44M | 172.09% |
Free cash flow | 40.85M | 249.41% |
Previous close
$19.42
Day range
$18.88 - $19.67
Year range
$5.90 - $23.63
Market cap
4.64B USD
Avg Volume
3.20M
P/E ratio
24.16
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2004
Headquarters
Website
Employees
685
